# Jérôme Lambert

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jerome-lambert/

## Facts

| Field | Value |
| --- | --- |
| Citations | 8,829 |
| Field | Multiple Myeloma Research and Treatments |
| h-index | 51 |
| i10-index | 128 |
| Last Known Institution | Inserm |
| OpenAlex ID | https://openalex.org/A5047625349 |
| ORCID iD | 0000-0001-7086-9295 |
| Works | 329 |

## Researcher papers

- [Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study](https://scholariq.org/papers/bortezomib-thalidomide-and-dexamethasone-with-or-without-daratumumab-before-and/)
- [Outcomes of Critically Ill Patients With Hematologic Malignancies: Prospective Multicenter Data From France and Belgium—A Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique Study](https://scholariq.org/papers/outcomes-of-critically-ill-patients-with-hematologic-malignancies-prospective/)
- [Diagnostic Strategy for Hematology and Oncology Patients with Acute Respiratory Failure: Randomized Controlled Trial](https://scholariq.org/papers/diagnostic-strategy-for-hematology-and-oncology-patients-with-acute-respiratory/)
- [Toward a <i>NOTCH1/FBXW7/RAS/PTEN</i> –Based Oncogenetic Risk Classification of Adult T-Cell Acute Lymphoblastic Leukemia: A Group for Research in Adult Acute Lymphoblastic Leukemia Study](https://scholariq.org/papers/toward-a-i-notch1-fbxw7-ras-pten-i-based-oncogenetic-risk-classification-of/)
- [Acquired Initiating Mutations in Early Hematopoietic Cells of CLL Patients](https://scholariq.org/papers/acquired-initiating-mutations-in-early-hematopoietic-cells-of-cll-patients/)
- [Delayed intensive care unit admission is associated with increased mortality in patients with cancer with acute respiratory failure](https://scholariq.org/papers/delayed-intensive-care-unit-admission-is-associated-with-increased-mortality-in/)
- [Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial](https://scholariq.org/papers/maintenance-with-daratumumab-or-observation-following-treatment-with-bortezomib/)
- [Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab](https://scholariq.org/papers/long-term-outcome-of-patients-with-steroid-refractory-acute-severe-uc-treated/)
- [Noninvasive mechanical ventilation in patients having declined tracheal intubation](https://scholariq.org/papers/noninvasive-mechanical-ventilation-in-patients-having-declined-tracheal/)
- [The effects of a 2-h trial of high-flow oxygen by nasal cannula versus Venturi mask in immunocompromised patients with hypoxemic acute respiratory failure: a multicenter randomized trial](https://scholariq.org/papers/the-effects-of-a-2-h-trial-of-high-flow-oxygen-by-nasal-cannula-versus-venturi/)
- [Survival of amyotrophic lateral sclerosis patients after admission to the intensive care unit for acute respiratory failure: an observational cohort study](https://scholariq.org/papers/survival-of-amyotrophic-lateral-sclerosis-patients-after-admission-to-the/)

## Researcher topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Sepsis Diagnosis and Treatment](https://scholariq.org/topics/sepsis-diagnosis-and-treatment/)
- [Nonmelanoma Skin Cancer Studies](https://scholariq.org/topics/nonmelanoma-skin-cancer-studies/)
- [Cancer and Skin Lesions](https://scholariq.org/topics/cancer-and-skin-lesions/)

## Researcher university

- [Inserm](https://scholariq.org/institutions/inserm/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.